Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond.

de Bernardi, Axel; Dufresne, Armelle; Mishellany, Florence; Blay, Jean-Yves; Ray-Coquard, Isabelle; Brahmi, Mehdi

de Bernardi, Axel; Dufresne, Armelle; Mishellany, Florence; Blay, Jean-Yves; Ray-Coquard, Isabelle; Brahmi, Mehdi.

Afiliação

de Bernardi A; Department of Medical Oncology, Centre Léon Bérard, 28 Rue Laennec, 69008 Lyon, France.
Dufresne A; Department of Medical Oncology, Centre Léon Bérard, 28 Rue Laennec, 69008 Lyon, France.
Mishellany F; Department of Pathology, Centre Jean Perrin, 58 Rue Montalembert, 63011 Clermont-Ferrand, France.
Blay JY; Department of Medical Oncology, Centre Léon Bérard, 28 Rue Laennec, 69008 Lyon, France.
Ray-Coquard I; Faculty of Medicine, Université Claude Bernard Lyon 1, 69003 Lyon, France.
Brahmi M; Department of Medical Oncology, Centre Léon Bérard, 28 Rue Laennec, 69008 Lyon, France.

Cancers (Basel) ; 14(4)2022 Feb 20.

Article em En | MEDLINE | ID: mdl-35205812

Palavras-chave

SFT; antiangiogenics; immune-checkpoint inhibitors; rare sarcoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google